Home CAR-T NCI Grants University of Pennsylvania $10.7 Million to Study CAR T-Cell Therapy...

NCI Grants University of Pennsylvania $10.7 Million to Study CAR T-Cell Therapy for Solid Tumors

275
0

Healio reports that the National Cancer Institute (NCI) will grant $10.7 million to the University of Pennsylvania’s Abramson Cancer Center to evaluate the use of chimeric antigen receptor T-cell therapy for treatment of solid tumors.  It is noted in Healio that investigators with Abramson’s Translational Center of Excellence for Lung Cancer Immunology will focus on CAR T-cell therapy approaches in lung cancer and mesothelioma.

Lead Research/Investigator

Steven M. Albelda, MD

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.